Zeillinger R[Author] - Search Results

Year	Number of Results
1984	1
1988	1
1989	2
1990	3
1991	3
1992	6
1993	6
1994	3
1995	5
1996	13
1997	11
1998	8
1999	8
2000	4
2001	5
2002	12
2003	9
2004	9
2005	17
2006	5
2007	11
2008	3
2009	8
2010	14
2011	17
2012	15
2013	19
2014	9
2015	12
2016	13
2017	9
2018	5
2019	5
2020	6
2021	1

1

Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer.

Obermayr E, Agreiter C, Schuster E, Fabikan H, Weinlinger C, Baluchova K, Hamilton G, Hochmair M, Zeillinger R. Obermayr E, et al. Among authors: zeillinger r. Cells. 2019 Aug 13;8(8):880. doi: 10.3390/cells8080880. Cells. 2019. PMID: 31412616 Free PMC article.

2

Correlation of circular RNA abundance with proliferation--exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues.

Bachmayr-Heyda A, Reiner AT, Auer K, Sukhbaatar N, Aust S, Bachleitner-Hofmann T, Mesteri I, Grunt TW, Zeillinger R, Pils D. Bachmayr-Heyda A, et al. Among authors: zeillinger r. Sci Rep. 2015 Jan 27;5:8057. doi: 10.1038/srep08057. Sci Rep. 2015. PMID: 25624062 Free PMC article.

3

Gene Expression of Kallikreins in Breast Cancer Cell Lines.

Watrowski R, Castillo-Tong DC, Obermayr E, Zeillinger R. Watrowski R, et al. Among authors: zeillinger r. Anticancer Res. 2020 May;40(5):2487-2495. doi: 10.21873/anticanres.14219. Anticancer Res. 2020. PMID: 32366393

4

miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients.

Panoutsopoulou K, Avgeris M, Magkou P, Mavridis K, Dreyer T, Dorn J, Obermayr E, Reinthaller A, Michaelidou K, Mahner S, Vergote I, Loverix L, Braicu I, Sehouli J, Zeillinger R, Magdolen V, Scorilas A. Panoutsopoulou K, et al. Among authors: zeillinger r. Int J Cancer. 2020 Dec 15;147(12):3560-3573. doi: 10.1002/ijc.33182. Epub 2020 Aug 1. Int J Cancer. 2020. PMID: 32621752 Review.

5

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer.

Kasimir-Bauer S, Roder J, Obermayr E, Mahner S, Vergote I, Loverix L, Braicu E, Sehouli J, Concin N, Kimmig R, Net L, Roder H, Zeillinger R, Aust S, On Behalf Of The Ovcad Ovarian Cancer Diagnosis Initiative. Kasimir-Bauer S, et al. Among authors: zeillinger r. Cancers (Basel). 2020 Sep 4;12(9):2519. doi: 10.3390/cancers12092519. Cancers (Basel). 2020. PMID: 32899818 Free PMC article.

6

Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer.

Meshcheryakova A, Svoboda M, Jaritz M, Mungenast F, Salzmann M, Pils D, Cacsire Castillo-Tong D, Hager G, Wolf A, Braicu EI, Sehouli J, Lambrechts S, Vergote I, Mahner S, Birner P, Zimmermann P, Brindley DN, Heinze G, Zeillinger R, Mechtcheriakova D. Meshcheryakova A, et al. Among authors: zeillinger r. Comput Struct Biotechnol J. 2019 Apr 10;17:537-560. doi: 10.1016/j.csbj.2019.04.004. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 31049165 Free PMC article.

7

Patient satisfaction after breast cancer surgery : A prospective clinical trial.

Leser C, Tan YY, Singer C, Zeillinger R, Fitzal F, Lehrner J, König D, Deutschmann C, Gschwantler-Kaulich D. Leser C, et al. Among authors: zeillinger r. Wien Klin Wochenschr. 2021 Jan;133(1-2):6-13. doi: 10.1007/s00508-020-01730-w. Epub 2020 Sep 3. Wien Klin Wochenschr. 2021. PMID: 32880714 Free PMC article. Clinical Trial.

8

Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines.

Rath B, Klameth L, Plangger A, Hochmair M, Ulsperger E, Huk I, Zeillinger R, Hamilton G. Rath B, et al. Among authors: zeillinger r. Cancers (Basel). 2019 Jan 19;11(1):114. doi: 10.3390/cancers11010114. Cancers (Basel). 2019. PMID: 30669448 Free PMC article.

9

miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study.

Panoutsopoulou K, Avgeris M, Mavridis K, Dreyer T, Dorn J, Obermayr E, Reinthaller A, Michaelidou K, Mahner S, Vergote I, Vanderstichele A, Braicu I, Sehouli J, Zeillinger R, Magdolen V, Scorilas A. Panoutsopoulou K, et al. Among authors: zeillinger r. Carcinogenesis. 2020 Jun 17;41(4):442-451. doi: 10.1093/carcin/bgz163. Carcinogenesis. 2020. PMID: 31586203

10

Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan.

Salk JJ, Loubet-Senear K, Maritschnegg E, Valentine CC, Williams LN, Higgins JE, Horvat R, Vanderstichele A, Nachmanson D, Baker KT, Emond MJ, Loter E, Tretiakova M, Soussi T, Loeb LA, Zeillinger R, Speiser P, Risques RA. Salk JJ, et al. Among authors: zeillinger r. Cell Rep. 2019 Jul 2;28(1):132-144.e3. doi: 10.1016/j.celrep.2019.05.109. Cell Rep. 2019. PMID: 31269435 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results